mirtazapine has been researched along with Out-of-Hospital Cardiac Arrest in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Out-of-Hospital Cardiac Arrest: Occurrence of heart arrest in an individual when there is no immediate access to medical personnel or equipment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eroglu, TE | 1 |
| Barcella, CA | 1 |
| Gerds, TA | 1 |
| Kessing, LV | 1 |
| Zylyftari, N | 1 |
| Mohr, GH | 1 |
| Kragholm, K | 1 |
| Polcwiartek, C | 1 |
| Wissenberg, M | 1 |
| Folke, F | 1 |
| Tan, HL | 1 |
| Torp-Pedersen, C | 1 |
| Gislason, GH | 1 |
1 other study available for mirtazapine and Out-of-Hospital Cardiac Arrest
| Article | Year |
|---|---|
Risk of out-of-hospital cardiac arrest in antidepressant drug users.
Topics: Antidepressive Agents; Case-Control Studies; Citalopram; Humans; Mirtazapine; Norepinephrine; Out-of | 2022 |